Prevalence of New-Onset Depression and Anxiety After Temporal Lobectomy
The prevalence of new-onset depression following temporal lobectomy for intractable seizures ranges from 0% to 38%, with new-onset anxiety occurring in approximately 16-33% of patients, typically manifesting within the first 3 months postoperatively 1, 2, 3.
Key Prevalence Data
Depression:
- De novo depression incidence varies widely from 0% to 38% across studies with follow-up periods ranging from 3 months to 9 years 4
- In a prospective 2-year study, 16.4% of patients without preoperative psychopathology developed mood or anxiety disorders postoperatively, with major depressive disorder occurring in 13 patients 2
- Another study found 20% developed new psychiatric disorders within 3 months post-surgery 1
Anxiety:
- Approximately 33% of patients develop anxiety symptoms in the early postoperative period 3
- New-onset anxiety disorders were documented in 28% of patients at 3 months post-surgery 1
Critical Timing Considerations
Most psychiatric complications occur within the first 2 months after surgery 5. However, patients who experience seizure recurrence may develop psychiatric symptoms later in their course 5, 2. More than half of new-onset mood or anxiety disorders manifest within the first year postoperatively 2.
Risk Factors for New-Onset Psychiatric Symptoms
The following factors predict higher risk of developing postoperative depression or anxiety:
- Younger age at surgery (mean 27.9 vs 34.8 years in those without symptoms) 3
- Higher preoperative anxiety scores on standardized scales 3
- Right-sided temporal lobectomy (statistically significant association) 3
- Past psychiatric history even if asymptomatic at time of surgery 2
- Seizure recurrence after surgery - 42% of previously intact patients who had seizure recurrence developed dysphoric disorders 5
- High preoperative seizure frequency 1
Important Clinical Context
While these numbers may seem concerning, the overall psychiatric outcome is generally favorable. Most studies show that the total prevalence of psychiatric disorders actually decreases after surgery - from 22% preoperatively to 9.9% at 2 years in one prospective study 2. Additionally, in patients with preoperative mood or anxiety disorders, 56% experienced remission or resolution after surgery 2.
Clinical Implications
All postoperative psychiatric complications that developed in compliant patients responded to treatment with psychotropic medication 5. The most significant predictor of excellent psychiatric outcome is complete seizure freedom after surgery 5. This underscores that while new-onset psychiatric symptoms do occur, they are treatable and the overall psychiatric burden typically improves with successful epilepsy surgery.
The high variability in reported prevalence (0-38% for depression) reflects differences in assessment timing, measurement tools, and patient populations across studies 4. Despite this heterogeneity, timely psychosocial follow-up for all patients after temporal lobectomy should be considered standard practice 4, particularly during the first 3 months when risk is highest.